van Egmond S, Hoedemaker C, Sinclair R. Successful treatment of perianal Bowen’s disease with imiquimod. Int J
Dermatol. 2007;46(3):318–319....
Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral
compounds activate immune cells via the TLR7 MyD88-
dependent signaling pathway. Nat...
Schön MP, Schön M. Immune modulation and apoptosis
induction: two sides of the antitumoral activity of imiquimod.
Apoptosis 2004;9(3):291–298....
Kim EJ, Hess S, Richardson SK, et al. Immunopathogenesis and
therapy of cutaneous T cell lymphoma. J Clin Invest. 2005;115
(4):798–812. https://doi.org/10.1172/JCI24826.
Gibson SJ, Lindh JM, Riter TR, et al. Plasmacytoid dendritic
cells produce cytokines and mature in response to the TLR7
agonists, imiquimod...
Akira S, Hemmi H. Recognition of pathogen-associated
molecular patterns by TLR family. Immunol Lett. 2003;85(2):
85–95. https://doi.org/10.1016/S0165-2478(02)00228-6.
Dummer R, Urosevic M, Kempf W, et al. Imiquimod in basal
cell carcinoma: how does it work? Br J Dermatol. 2003;149(s66):
57–58. https://doi.org/10.1046/j.0366-077X.2003.05630.x.
Otero M, Calarota SA, Felber B, et al. Resiquimod is a modest
adjuvant for HIV-1 gag-based genetic immunization in a
mouse model. DNA Vaccines...
Ambach A, Bonnekoh B, Nguyen M, et al. Imiquimod, a Tolllike receptor-7 agonist, induces perforin in cytotoxic T
lymphocytes in vitro. Mol...
Lester SN, Li K. Toll-like receptors in antiviral innate immunity. Antivir Innate Immun Part II. 2014;426(6):1246–1264. https://
doi.org/10.1016/j.jmb.2013.11.024.
Zhu J, Lai K, Brownile R, et al. Porcine TLR8 and TLR7 are both
activated by a selective TLR7 ligand, imiquimod. Mol Immunol.
2008;45(11):3238–3243....
Gorden KB, Gorski KS, Gibson SJ, et al. Synthetic TLR agonists
reveal functional differences between human TLR7 and TLR8.
J Immunol Baltim...
Rendic S. Summary of information on human CYP enzymes:
human P450 metabolism data. Drug Metab Rev. 2002;34(1-2):
83–448. https://doi.org/10.1081/dmr-120001392.
Shipman AR, Scarisbrick J. New treatment options for mycosis
fungoides. Indian J Dermatol. 2016;61(1):119. https://doi.org/10.
4103/0019-5154.174085.
Huen AO, Rook AH. Toll receptor agonist therapy of skin
cancer and cutaneous T-cell lymphoma. Curr Opin Oncol. 2014;
26(2):237–244. https://doi.org/10.1097/CCO.0000000000000048.
Tarabadkar ES, Shinohara MM. Skin directed therapy in
cutaneous T-Cell lymphoma. Front Oncol. 2019;9:260. https://
doi.org/10.3389/fonc.2019.00260.
Gordon MC, Sluzevich JC, Jambusaria-Pahlajani A. Clearance
of folliculotropic and tumor mycosis fungoides with topical
5% imiquimod. JAAD...
Shalabi D, Vadalia N, Nikbakht N. Revisiting imiquimod for
treatment of folliculotropic mycosis fungoides: a case report
and review of the...
Martínez-González MC, Verea-Hernando MM, Yebra-Pimentel
MT, et al. Imiquimod in mycosis fungoides. Eur J Dermatol EJD.
2008;18(2):148–152....
Deeths MJ, Chapman JT, Dellavalle RP, et al. Treatment of
patch and plaque stage mycosis fungoides with imiquimod
5% cream. J Am Acad Dermatol....
Coors EA, Schuler G, Von Den Driesch P. Topical imiquimod as
treatment for different kinds of cutaneous lymphoma. Eur J
Dermatol EJD. 2006;16(4):391–393.
Chong A, Loo WJ, Banney L, et al. Imiquimod 5% cream in the
treatment of mycosis fungoides–a pilot study. J Dermatol Treat.
2004;15(2):118–119....
Suchin KR, Junkins-Hopkins JM, Rook AH, Hospital of the
University of Pennsylvania P. Treatment of stage IA cutaneous
T-cell lymphoma with...
Del Guzzo CA, Kojadinovic A, Vinnakota RR, et al. Antibiotics
and imiquimod for cutaneous T-cell lymphoma in veterans: a
patient population...
Lewis DJ, Byekova YA, Emge DA, et al. Complete resolution of
mycosis fungoides tumors with imiquimod 5% cream: a case
series. J Dermatol Treat....
Richardson SK, Lin JH, Vittorio CC, et al. High clinical response
rate with multimodality immunomodulatory therapy for
Sézary syndrome. Clin...
